JP2014530627A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014530627A5 JP2014530627A5 JP2014537358A JP2014537358A JP2014530627A5 JP 2014530627 A5 JP2014530627 A5 JP 2014530627A5 JP 2014537358 A JP2014537358 A JP 2014537358A JP 2014537358 A JP2014537358 A JP 2014537358A JP 2014530627 A5 JP2014530627 A5 JP 2014530627A5
- Authority
- JP
- Japan
- Prior art keywords
- melanoma
- cell
- vaccine
- cells
- apoptotic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161549681P | 2011-10-20 | 2011-10-20 | |
| US61/549,681 | 2011-10-20 | ||
| US201261594304P | 2012-02-02 | 2012-02-02 | |
| US61/594,304 | 2012-02-02 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2014530627A JP2014530627A (ja) | 2014-11-20 |
| JP2014530627A5 true JP2014530627A5 (enExample) | 2016-02-25 |
Family
ID=48141460
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014537358A Pending JP2014530627A (ja) | 2011-10-20 | 2012-10-22 | 抗原提示癌ワクチン |
| JP2014537355A Pending JP2014533938A (ja) | 2011-10-20 | 2012-10-22 | γインターフェロンを用いた抗原提示癌ワクチン |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014537355A Pending JP2014533938A (ja) | 2011-10-20 | 2012-10-22 | γインターフェロンを用いた抗原提示癌ワクチン |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US9555058B2 (enExample) |
| EP (2) | EP2768519A4 (enExample) |
| JP (2) | JP2014530627A (enExample) |
| KR (2) | KR20150004791A (enExample) |
| CN (5) | CN105999249A (enExample) |
| AU (2) | AU2012325758A1 (enExample) |
| CA (2) | CA2852967A1 (enExample) |
| HK (2) | HK1201175A1 (enExample) |
| IL (2) | IL232173A0 (enExample) |
| SG (4) | SG11201401632WA (enExample) |
| WO (2) | WO2013059778A2 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2865830B1 (fr) | 2004-01-30 | 2006-05-19 | Neopost Ind | Systeme d'affranchissement de courrier a mode d'impression externe securise |
| SG11201401632WA (en) * | 2011-10-20 | 2014-05-29 | California Stem Cell Inc | Antigen presenting cancer vaccine |
| CN103599528B (zh) * | 2013-12-04 | 2015-08-05 | 深圳市合一康生物科技股份有限公司 | 人树突状细胞疫苗的制备方法 |
| CN107109365A (zh) * | 2014-07-17 | 2017-08-29 | 布莱恩·J·赫尔尼奇 | 多剂量注射用树突状细胞疫苗的制备及用于阻断her2和her3的联合治疗 |
| AU2017261353A1 (en) * | 2016-05-05 | 2018-11-08 | Nantomics, Llc | Checkpoint failure and methods therefor |
| EP3582793A4 (en) * | 2017-02-17 | 2020-12-16 | Aivita Biomedical, Inc. | METHODS TO IMPROVE TUMOR IMMUNOGENICITY AND COMPOSITIONS FOR AUTOLOGOUS ANTI-CANCER IMMUNOTHERAPEUTICS USING MODIFIED TUMOR CELLS AND MODIFIED DENDRITIC CELLS |
| WO2024107624A1 (en) * | 2022-11-14 | 2024-05-23 | Shattuck Labs, Inc. | Methods of overcoming resistance to checkpoint inhibitor therapies |
| CN118441033B (zh) * | 2024-04-24 | 2025-06-20 | 广西医科大学 | HLA-DPB1*05:01在抗γ干扰素自身抗体所致获得性免疫缺陷筛查中的应用 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU669379B2 (en) * | 1992-09-07 | 1996-06-06 | Kyowa Hakko Kirin Co., Ltd. | Humanized antibodies |
| US5874560A (en) * | 1994-04-22 | 1999-02-23 | The United States Of America As Represented By The Department Of Health And Human Services | Melanoma antigens and their use in diagnostic and therapeutic methods |
| AU2872199A (en) | 1998-02-20 | 1999-09-06 | Rockefeller University, The | Apoptotic cell-mediated antigen presentation to dendritic cells |
| ES2340358T3 (es) | 1999-10-15 | 2010-06-02 | Baylor Research Institute | Uso de lineas celulares alogenicas para cargar celulas que presentan antigenos para elicitar respuestas inmunes. |
| US7015205B1 (en) * | 1999-10-18 | 2006-03-21 | St. Vincent's Hospital And Medical Center Of New York | Melanoma vaccine and methods of making and using same |
| US7771998B2 (en) * | 2001-11-29 | 2010-08-10 | Dandrit Biotech A/S | Pharmaceutical composition for inducing an immune response in a human or animal |
| GB0130720D0 (en) * | 2001-12-21 | 2002-02-06 | Serono Internat S A | Proteins |
| CN1443778A (zh) * | 2002-03-13 | 2003-09-24 | 上海中信国健药业有限公司 | 一种黑色素瘤相关抗原的单克隆抗体及其用途和药物组合物 |
| JP5623004B2 (ja) | 2004-10-25 | 2014-11-12 | ベイラー リサーチ インスティテュートＢａｙｌｏｒ Ｒｅｓｅａｒｃｈ Ｉｎｓｔｉｔｕｔｅ | 熱ショックをかけたメラノーマ細胞体が装填された樹状細胞 |
| WO2007016340A2 (en) * | 2005-07-29 | 2007-02-08 | Providence Health System | Defective ribosomal products in blebs (dribbles) and methods of use to stimulate an immune response |
| CA2628477A1 (en) * | 2005-11-07 | 2007-05-10 | Bc Cancer Agency | Inhibition of autophagy genes in cancer chemotherapy |
| MY160857A (en) * | 2006-02-03 | 2017-03-31 | Malaysian Palm Oil Board | A cancer vaccine |
| CN101511384A (zh) * | 2006-06-30 | 2009-08-19 | 贝勒研究院 | 采用GM-CSF和α干扰素制成的并装载热处理的且杀死的癌细胞的树突状细胞 |
| AR060424A1 (es) | 2007-04-11 | 2008-06-18 | Consejo Nac Invest Cient Tec | Lineas celulares , composiciones para el tratamiento de melanomas que las comprenden procedimientos para preparar las composiciones y metodos de tratamiento |
| GB0713116D0 (en) * | 2007-07-06 | 2007-08-15 | Therapeutics Ltd E | Treatment of melanoma |
| US20090041792A1 (en) * | 2007-07-19 | 2009-02-12 | Istituto Superiore Di Sanita | Dendritic cells, uses therefor, and vaccines and methods comprising the same |
| SG11201401632WA (en) | 2011-10-20 | 2014-05-29 | California Stem Cell Inc | Antigen presenting cancer vaccine |
-
2012
- 2012-10-22 SG SG11201401632WA patent/SG11201401632WA/en unknown
- 2012-10-22 CN CN201610301904.7A patent/CN105999249A/zh active Pending
- 2012-10-22 CA CA2852967A patent/CA2852967A1/en not_active Abandoned
- 2012-10-22 CN CN201280051799.6A patent/CN103917246A/zh active Pending
- 2012-10-22 KR KR1020147013355A patent/KR20150004791A/ko not_active Withdrawn
- 2012-10-22 JP JP2014537358A patent/JP2014530627A/ja active Pending
- 2012-10-22 US US14/352,983 patent/US9555058B2/en not_active Expired - Fee Related
- 2012-10-22 KR KR1020147013353A patent/KR20150016200A/ko not_active Withdrawn
- 2012-10-22 JP JP2014537355A patent/JP2014533938A/ja active Pending
- 2012-10-22 SG SG10201602424RA patent/SG10201602424RA/en unknown
- 2012-10-22 HK HK15101635.2A patent/HK1201175A1/xx unknown
- 2012-10-22 SG SG11201401631VA patent/SG11201401631VA/en unknown
- 2012-10-22 CN CN201610218244.6A patent/CN105861437A/zh not_active Withdrawn
- 2012-10-22 SG SG10201508535RA patent/SG10201508535RA/en unknown
- 2012-10-22 WO PCT/US2012/061294 patent/WO2013059778A2/en not_active Ceased
- 2012-10-22 AU AU2012325758A patent/AU2012325758A1/en not_active Abandoned
- 2012-10-22 HK HK15101637.0A patent/HK1201176A1/xx unknown
- 2012-10-22 EP EP12841839.9A patent/EP2768519A4/en not_active Withdrawn
- 2012-10-22 CN CN201280051821.7A patent/CN103957925A/zh active Pending
- 2012-10-22 CN CN201510706438.6A patent/CN105288602A/zh active Pending
- 2012-10-22 US US14/352,982 patent/US20140308316A1/en not_active Abandoned
- 2012-10-22 AU AU2012325764A patent/AU2012325764A1/en not_active Abandoned
- 2012-10-22 WO PCT/US2012/061306 patent/WO2013059784A1/en not_active Ceased
- 2012-10-22 CA CA2852960A patent/CA2852960A1/en not_active Abandoned
- 2012-10-22 EP EP12842230.0A patent/EP2768534A4/en not_active Withdrawn
-
2014
- 2014-04-22 IL IL232173A patent/IL232173A0/en unknown
- 2014-04-22 IL IL232172A patent/IL232172A0/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014530627A5 (enExample) | ||
| JP2014533938A5 (enExample) | ||
| Hailemichael et al. | Persistent antigen at vaccination sites induces tumor-specific CD8+ T cell sequestration, dysfunction and deletion | |
| Padte et al. | A glycolipid adjuvant, 7DW8-5, enhances CD8+ T cell responses induced by an adenovirus-vectored malaria vaccine in non-human primates | |
| Perret et al. | Adjuvants that improve the ratio of antigen-specific effector to regulatory T cells enhance tumor immunity | |
| Hope et al. | Striking a balance—cellular and molecular drivers of memory T cell development and responses to chronic stimulation | |
| PL2102331T3 (pl) | Szczepionka przeciwnowotworowa otrzymana z prawidłowych, chemicznie modyfikowanych komórek CD4+ | |
| JP2021502414A5 (enExample) | ||
| MX2020011675A (es) | Peptidos novedosos y acidos nucleicos de los mismos contra tumores tal como los de cancer gastrico y gastrointestinal. | |
| JP2010514455A5 (enExample) | ||
| MX2018007295A (es) | Interleucina 10 en la produccion de linfocitos t cd8+especificos para el antigeno y metodos de uso de estos. | |
| BR112016009402A2 (pt) | Peptídeo, linfócitos t citotóxicos (ltc) ativados, método para sua produção, anticorpo, receptor de células t, ácido nucleico, célula hospedeira, uso dos mesmos, kit, método para produzir uma vacina anticâncer personalizada para um paciente individual | |
| JP2014514927A5 (enExample) | ||
| MX2017008329A (es) | Nuevos peptidos y nueva combinacion de peptidos para el uso en la inmunoterapia contra el carcinoma hepatocelular (chc) y otros tipos de cancer. | |
| WO2012054509A3 (en) | Discovery of regulatory t cells programmed to suppress an immune response | |
| JP2013177430A5 (enExample) | ||
| Aspord et al. | pDCs efficiently process synthetic long peptides to induce functional virus‐and tumour‐specific T‐cell responses | |
| TR201905447T4 (tr) | Yeni mhc bağımsız tümörle ilişkili antijenler. | |
| JP2015506698A5 (enExample) | ||
| EP4574159A3 (en) | Optimally activated dendritic cells that induce an improved or increased anti-tumor immune response | |
| US9089593B2 (en) | Dendritic cell tumor injection (DCTI) therapy | |
| Yang et al. | HCA587 protein vaccine induces specific antitumor immunity mediated by CD4+ T-cells expressing granzyme B in a mouse model of melanoma | |
| RU2012103822A (ru) | Способ генерации антиген-специфических цитотоксических клеток с активностью против клеток рака яичника | |
| Ota et al. | Vaccination of acute leukemia patients with WT1 peptide-pulsed dendritic cells induces immunological and clinical responses: a pilot study | |
| Schmittling | Data from Recognition and Killing of Autologous, Primary Glioblastoma Tumor Cells by Human Cytomegalovirus pp65-Specific Cytotoxic T Cells |